Lupin | Page 2 | Business Upturn

Latest Articles

Lupin receives U.S. FDA nod for Lenalidomide Capsules

Corporates · Sep 17, 2025

blank

Top stocks to watch today, September 17: L&T, Coal India, BEL, NLC India, Lupin, Mobikwik and more

Stock Market · Sep 17, 2025

blank

Lupin share price jumps over 2% after Investec upgrades to Buy, raises target price to ₹2,265

Stock Market · Sep 12, 2025

blank

[Brokerages] Stocks to watch today, Sep 12: Citi on autos, Investec on Lupin, Infosys in focus after record buyback

Brokerages · Sep 12, 2025

By Arunika Jain

blank

Top stocks to watch today, September 11: Infosys, Mazagon Dock, Lupin, Bajaj Finserv and more

Stock Market · Sep 11, 2025

blank

Top stocks to watch today, August 6: Bharti Airtel, Lupin, Britannia, NCC, Gland Pharma and more

Stock Market · Aug 6, 2025

blank

Lupin Season 4: Release date speculation, cast and plot details – Everything we know so far

OTT · Jul 22, 2025

blank

Top stocks in focus on July 17: Tech Mahindra, SBI, TVS Motor, Lupin, Ixigo, L&T Technology Services and more

Stock Market · Jul 17, 2025

blank

Lupin launches generic Lotemax ophthalmic suspension in the U.S. market

Corporates · Jul 16, 2025

By Aditya Bhagchandani

blank

Lupin shares jump 2% after company signs licensing and supply agreement with Zentiva

Stock Market · Jul 9, 2025

blank

Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray) in the US market

Corporates · Jul 4, 2025

blank

Lupin gets USFDA nod for Loteprednol Etabonate Ophthalmic Gel; Eligible for 180-day generic exclusivity

Corporates · Jul 1, 2025

blank

Lupin carves out LupinLife into separate consumer healthcare subsidiary to focus on OTC consumer wellness market

Corporates · Jul 1, 2025

blank

Lupin gets U.S. FDA nod for Prucalopride Tablets for treatment of CIC in adults

Corporates · Jun 25, 2025

blank

Lupin shares in focus after US Court rejects plea in Astellas Patent case

Stock Market · Jun 13, 2025

Showing 30 of 87 articles